Radiation therapy for esophageal cancer in patients over 80 years old

doi:10.1016/0360-3016(94)90333-6

International Journal of Radiation OncologyBiologyPhysics

Volume 30, Issue 5, 1 December 1994, Pages 1225-1232

https://doi.org/10.1016/0360-3016(94)90333-6 Get rights and content

Abstract

$Purpose$ : A retrospective analysis was performed to investigate the treatment outcome and the significance of radiation therapy for esophageal cancer in patients over 80 years old.

$Methods and Materials$ : Between 1971 and 1990, 257 patients with squamous cell carcinoma of the esophagus were treated by radiation therapy. Of these, 40 patients over eighty years old were investigated. The reasons for radiation therapy were advanced age alone in 22 patients, Stage IV disease in 13, and medical problems in 5. Of these, 33 patients (83%) could be irradiated over 60 Gy. The cases with Stage I to III disease who received 60 Gy or more were defined as the curative radiation therapy group, and the others were defined as the palliative radiation therapy group. Actuarial survival rates were determined by the Kaplan-Meier method.

$Results$ : The 5-year disease-specific survival rate for the curative radiation therapy group (n = 25) was 34% with three intercurrent deaths. None of the patients in the palliative radiation therapy group (n = 15), including 13 cases with Stage IV and two given-up cases, survived over 2 years. No severe radiation damage was observed in either group. The 5-year disease-specific survival rate was 64% for complete response cases of local response, and 8% for partial response and no change cases (p < 0.01). The 5-year disease-specific survival rate was 64% for the patients with tumors less than 5 cm in length, and 8% for the patients with tumors over 5 cm in length (p < 0.001). No significant survival differences were found in regard to sex and tumor location. The patients with superficial spreading type and polypoid type tumors according to the radiologic findings had better prognoses than the patients with ulcerative type and circumferential type tumors.

$Conclusions$ : Radiation therapy is a safe and effective treatment for esophageal cancer in patients over 80 years old.

References (12)

Y. Hishikawa et al.
Radiotherapy for carcinoma of the esophagus in patients aged eighty or older
Int. J. Radiat. Oncol. Biol. Phys.
(1991)
K. Cho et al.
Radiotherapy for esophageal cancers in aged patients over 80
Jpn. J. Cancer Clin.
(1991)
S.C. Fisher et al.
Carcinoma of the esophagus
Health and Welfare Statistics Association
Kokumin-eiseino-doukou
Japanese Society for Esophageal Diseases
S. Katano et al.
Radiotherapy for non-small cell lung cancer in the elderly
Lung Cancer
(1992)

There are more references available in the full text version of this article.

Cited by (32)

Head and neck cancer in the elderly: An overview on the treatment modalities
2009, Cancer Treatment Reviews
Citation Excerpt :
Preliminary clinical results of IMRT are encouraging for the treatment of SCCHN.54,56,57 Several studies have shown that RT is effective and well tolerated in an ageing population and age does not represent a limiting factor for radiation therapy.8,58–62 Two decades ago, a large retrospective study reviewed 249 elderly patients treated with radical irradiation for cancers of the upper aerodigestive tract and 59 elderly patients who received radiation therapy with a palliative intent.
The percentage of elderly people with head and neck cancers (HNC) is rising due to increasing average lifespan. As with younger patients, elderly patients require a multidisciplinary approach in order to optimise treatment results. The biological, not the chronological, age should be defined individually based on co-morbidities and performance status. A comprehensive geriatric assessment represents the first and essential step for selecting further treatment options. Major improvements have been accomplished in surgical techniques and radiotherapy delivery. Several chemotherapeutic agents and targeted therapies with different toxicity profile are also available. However, the randomised studies that defined the nature of these improvements included only a small proportion of patients older than 65 years. In deciding which treatment strategy would be suitable for an individual elderly patient, we review the literature regarding surgery, radiotherapy, and chemotherapy or their various combinations.
A 104-year-old woman with advanced cervical carcinoma of the uterus
2004, Gynecologic Oncology
Background. Treatment of elderly patient with advanced cancer includes considerable problems because of their limited life expectancy.
Case. A 104-year-old woman with FIGO stage IIIB uterine cervical carcinoma treated with external beam radiotherapy and high dose-rate brachytherapy. After the treatment, the serum squamous cell carcinoma (SCC) antigen had fallen to normal level. She is now living 66 months after the treatment without recurrent symptoms.
Conclusion. In this specific case, the significance of this treatment is that the patient is surviving at the age of 109.
A preliminary outcome analysis of the patterns of care study in Japan for esophageal cancer patients with special reference to age: Non surgery group
2000, International Journal of Radiation Oncology Biology Physics
Background: The Patterns of Care Study (PCS) was imported to Japan from the United States in July 1996. A preliminary outcome analysis of the PCS for esophageal cancer patients in Japan was made with special reference to age, because the elderly population is rapidly increasing in Japan.
Patients and Methods: From July 1996 to February 1998, external PCS audits were performed for 37 institutions nationwide and detailed information of 561 esophageal cancer patients treated during the period 1992–1994 was collected by using the fifth PCS data format developed in the United States. This format was provided courtesy of the American College of Radiology. For this study, patients who had not undergone surgery (n = 336) were selected. The patients were classified into three age groups: < 65 years old (n = 119), between 65 and 74 years (n = 93), and 75 years or older (n =123). Cox’s proportional hazards model was used for the statistical analysis, with survival, acute/subacute complication and late complication of grade 3 or more based on RTOG criteria, as the endpoints.
Results: Significant prognostic factors for the entire non-surgery group were Karnofsky Performance Status (KPS) (p = 0.0007), stage (p = 0.0001), and external irradiation dose (p = 0.0001). For the younger group, KPS (p = 0.0004), stage (p = 0.0197), and utilization of brachytherapy (p = 0.0010) were significant, while for the intermediate age group it was KPS (p = 0.0027), history of pulmonary disease (p = 0.0339), stage (p = 0.0001), and external dose (p = 0.0001), and for the elderly group, stage (p = 0.0001) and external irradiation dose (p = 0.0224) were significant. Significant risk factors for complications for the entire group were stage (p = 0.0411), external dose (p = 0.0163), and stratification of institution (academic vs. nonacademic) (p = 0.0114). Significant risk factors for the younger group were history of pulmonary disease (p = 0.0495) and external dose (p = 0.0037), and the other age groups showed no significant risk factors.
Conclusion: Age was not a significant prognostic or risk factor for esophageal cancer patients in the non-surgery group treated with radiation therapy. Therefore, radiation therapy represented an important treatment modality for the elderly as well as for the younger esophageal cancer patients. External dose was a treatment-related prognostic factor for the elderly as well as for the intermediate age group.
Radiation therapy of the older patient
2000, Hematology/Oncology Clinics of North America
Citation Excerpt :
They believe patients older than 90 years with good performance status may tolerate acute reactions of radiotherapy administered according to conventional fraction schedules. Two recent reports from Japan also favor a radical course of radiotherapy for patients aged over 80 years who have esophageal carcinoma.80,193 Yamakawa et al reported the results of treating 40 patients over the age of 80 years with esophageal cancer.193
Cancer in the geriatric population is a significant public health issue in the United States today. Currently, 60% of all malignant tumors occur in individuals aged 65 years and older. Nearly 70% of all cancer deaths occur in this age group. Currently about 12% of the population is over 65 years old, and this figure will rise to 20% in the year 2030.
As age advances, the incidence of cancer increases dramatically¹⁴⁸ in both men and women (Fig. 1). The effect of aging is more apparent in certain cancers. Thirty-five percent of all colon cancers occur in women aged 80 or older; the median age at diagnosis is 75 years. By age 90, 90% of men will have prostate cancer. The distribution of cancer incidence in persons aged 65 years and older is given in Table 1.
Currently, older patients with cancer are evaluated and treated less aggressively than their younger counterparts.⁵⁵ Older patients are less likely to receive combined-modality therapy.¹¹⁸ There are few clinical trials for patients over the age of seventy-five years. Older patients are excluded from the existing trials because of concerns regarding the toxicity and lack of benefit from treatment.67, 195
As an alternative to surgery and to systemic chemotherapy, ²³ radiotherapy is of particular benefit to older and frail cancer patients. It is widely used with curative and palliative intent. The information concerning the effectiveness and tolerance of radiation in the older patients is limited, however. Few books or publications have dealt with this aspect of oncology. Many older patients are either not treated or are undertreated because of the fear of treatment-related toxicities.40, 55, 70, 116, 156 Approximately two thirds of younger patients are managed by multimodality therapy, as compared with only one third of patients more than 75 years old.⁴¹ This article reviews the current information regarding the effectiveness and toxicity of radiotherapy in older individuals and presents the available data specific to major cancer sites.
Outcome of radiotherapy for the treatment of laryngeal squamous cell carcinoma in the very elderly population
2023, Journal of Laryngology and Otology
Management of elderly patients with esophageal squamous cell cancer
2022, Japanese Journal of Clinical Oncology

View all citing articles on Scopus

^☆: This work was presented at the International Congress of Radiation Oncology 1993 (ICRO '93), June, 1993, Kyoto, Japan (abstract no.: 0 46-1).

View full text

Brief communicationRadiation therapy for esophageal cancer in patients over 80 years old☆

Abstract

Int. J. Radiat. Oncol. Biol. Phys.

Radiotherapy for esophageal cancers in aged patients over 80

Jpn. J. Cancer Clin.

Carcinoma of the esophagus

Kokumin-eiseino-doukou

Radiotherapy for non-small cell lung cancer in the elderly

Lung Cancer

Brief communication
Radiation therapy for esophageal cancer in patients over 80 years old☆